Clinical services network- clinical trial planning and execution

Ended Awarded Last action

Contract number
75A50123F33006
Awardee
Awarding agency
Obligated
$330,226,484

Award facts

Contract value 100% obligated
$330,226,484.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Hinckley, OH 44233, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 · Clinical trial planning and execution - covid next generation vaccine $0
Terminate for Convenience P00006 · EOI::EO: radical transparency about wasteful spending::EOI notification of termination for convenience (complete) $0
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 · Clinical trial planning and execution - covid next generation vaccine $2,657,570
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $327,568,914

About this award

The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a delivery order valued at $330.2 million to Icon Government and Public Health Solutions, Inc. on August 22, 2023, for clinical trial planning and execution services supporting next-generation COVID-19 vaccine development. The contract, which operates on a cost-plus-fixed-fee basis with an ultimate completion date of April 11, 2025, will be performed in Hinckley, Ohio. This award did not utilize a set-aside designation, indicating open competition. Icon, a foreign-owned clinical research firm based in Blue Bell, Pennsylvania, specializes in comprehensive clinical trial support services across the federal government, with particular expertise in vaccine development and medical countermeasures addressing infectious disease threats.

This delivery order is issued under Icon's existing $550 million Clinical Trials Planning and Execution Indefinite Delivery/Indefinite Quantity (IDIQ) contract with ASPR, which enables rapid task order issuance for clinical research initiatives. Icon maintains an extensive portfolio of federal contracts with HHS, the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), the Department of Defense (DoD), and other agencies, supporting research activities ranging from protocol development and site selection to regulatory submissions and participant recruitment. The company's work on this COVID-19 vaccine initiative aligns with ASPR's mission to strengthen national health security and emergency preparedness through medical countermeasure development and clinical research.

Quick answers

Who was awarded contract 75A50123F33006?

75A50123F33006 was awarded to Icon Government And Public Health Solutions, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 22, 2023.

How much is contract 75A50123F33006 worth?

The government has obligated $330,226,484 on 75A50123F33006.

Is contract 75A50123F33006 an order under another contract?

Yes. 75A50123F33006 is a delivery order under 75A50120D00017, an indefinite delivery contract.

Was contract 75A50123F33006 competed?

The extent of competition for 75A50123F33006 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award